Objectives: To use extensive electronic dental, medical, and pharmacy databases to estimate the prevalence of dental caries in a cohort of new patients during a 5-year period (FY2010-FY2015) and determine whether medication use and medical comorbidities are associated with caries prevalence. Methods: This was a retrospective analysis of existing data from the Department of Veterans Affairs (VA). The number of teeth treated due to a caries-related diagnosis was determined and outcomes were presented as number of teeth/ person and proportion of patients receiving caries-related treatment. Logistic and negative binomial regression modeled teeth/person with caries-related treatment; covariates included age, gender, race, ethnicity, physical and mental comorbidities, and use of prescription medications and prescription drugs with strong anticholinergic properties. Results: The study population included 95,850 dentate dental patients: 92.1 percent were male, mean age of 58.7 AE 12.6 years, 73.2 percent were White/ Caucasian, and 21.3 percent were Black/African American. They were taking a mean of 10.6 AE 5.9 VA prescription drug classes, 0.6 AE 0.4 drugs with strong anticholinergic properties, and had 3.6 AE 2.2 physical and 1.4 AE 1.2 mental comorbidities. On average, 2.2 teeth/person received caries-related treatment and 58 percent of the study population received any caries-related treatment. An increase in the rate of caries-related treatment in Veterans was statistically significantly associated with increased prescription medication use; one or more drugs with strong anticholinergic properties and with 1+ mental comorbidities. Increased physical comorbidity was not statistically significantly associated with caries-related treatment. Conclusions: This study demonstrates a high prevalence of caries among Veteran dental patients, with an increased prevalence in those taking higher numbers of prescription medications.
Introduction
Dental caries still presents a significant disease burden. According to the Centers for Disease Control and Prevention (1), 26 percent of people in the 45-64-year age group had untreated caries in 2011-2012. Further, the Global Burden of Disease Study (2) showed that there was a 34.5 percent increase in years lived with disability due to dental caries for the 20-year period extending from 1990 to 2010. In addition, dental caries ranked as the most prevalent condition evaluated (35.3 percent prevalence rate for both sexes) among the 50 most common diseases globally. Second and third on this list were tension-type headache (20.7 percent) and migraine (14.7 percent), respectively. Lower back pain was 9th on the list (9.2 percent prevalence), while diabetic neuropathy was ranked 42nd (1.9 percent prevalence). Possible explanations for the large unmet need involving dental caries are access to care issues (3) and the aging of the population, at a time when more adults are retaining more teeth than ever before (4) .
There is definitive evidence that dental caries in adults does increase with increasing age, and Bernabé and colleagues (5) noted that this fact casts doubts on the assumption that prevention directed primarily at children would lead to major caries reductions throughout the population. Risk factors or determinants for this agerelated increase are also important. Systemic comorbidities such as hepatitis, high blood pressure, diabetes, and medication use may play a part in this age-related increase, but the interplay of all of these issues are still not fully understood (6, 7) .
With the introduction of electronic dental and medical records, great volumes of data can be collected and accessed quickly to answer epidemiologic, health outcomes, health services research, and comparative effectiveness research questions. Song and colleagues (8) found that reusing electronic data for research in dentistry is in its early stages, but rapidly increasing. Liu and colleagues (9) determined that "a non-trivial number of data elements in general dental records can be mapped either completely or partially to data fields in research studies."
The Department of Veterans Affairs (VA) presents a unique opportunity to analyze comprehensive electronic health records because of the ability to combine dental treatment records (containing CDT treatment and ICD-9/10 diagnostic codes) with medical inpatient/outpatient data, pharmacy records, and laboratory test results. This provides a platform to answer a variety of clinical questions that can inform clinical practice and improve patient care. During fiscal years 2010-2015, the VA Dental Services was composed of 221 active dental clinics and was organized into 138 administrative parent facilities. An average of 457,000 unique patients per year received dental treatment, and a steady increase in the number of patients treated over the past 5 years has been observed. Our previous studies have shown that Veterans receiving dental care in the VA dental service are more dentally impaired and medically complex than the general population (10) (11) (12) . The aim of the present study was to utilize electronic dental, medical, and pharmacy databases to estimate the prevalence of dental caries in a cohort of new continuous and comprehensive care Veteran outpatients during a 5-year period, and to determine whether prescription medication use and medical comorbidities are associated with caries prevalence. This information will provide insight regarding the patient population and can inform caries risk assessment and management strategies.
Methods

Study design
This was a retrospective analysis of existing data from the VA's electronic dental, medical, and pharmacy records. The study complies with the strengthening the reporting of observational studies in epidemiology statement guidelines for reporting observational studies (13) .
Institutional review
This study was approved by the Institutional Review Board at the Edith Nourse Rogers Memorial Veterans Hospital in Bedford, Massachusetts, and received a waiver of consent. All data analyses were conducted at this location.
Sample
The study population included all new continuous and comprehensive care dental outpatients who received an initial comprehensive exam (D0150) from FY10 through FY15 (October 1, 2009 through September 30, 2015) . Outpatients who received any treatment during the 36 months prior to this initial comprehensive exam were excluded from the study. Using the information contained within the Oral Health Assessment from the electronic dental record, patients identified as edentulous during their initial comprehensive exam were excluded from the study.
Data sources
Dental data were obtained from the Dental Encounter System, whereas the medical diagnosis data (Inpatient and Outpatient Medical SAS Datasets) were downloaded from the Austin Information Technology Center mainframe. The medication data were obtained through the VA's Managerial Cost Accounting System (formerly Decision Support System), which is accessed through the Corporate Data Warehouse. Age and gender were obtained from the VHA Vital Status Mini File, while race and ethnicity were obtained from the Medical SAS Inpatient and Outpatient Datasets. We supplemented missing race data with Medicare data from the Vital Status Master File. All analyses were conducted using SAS/STAT software (Version 9.3; SAS Institute, Cary, NC).
Outcomes measured
We evaluated the number of teeth/person treated due to a caries-related diagnosis (ICD-9 diagnostic codes: 521.00, 521.01, 521.02, 521.03, 521.06, 521.07, 521.08, 521.09). In particular, we evaluated teeth with direct restorations (D2140, D2150, D2160, D2161, D2330, D2331, D2332, D2335, D2390, D2391, D2392, D2393, D2394), teeth with indirect restorations (D2410, D2420, D2430, D2510, D2520, D2530, D2542, D2543, D2544, D2610, D2620, D2630, D2642, D2643, D2644, D2650, D2651, D2652, D2662, D2663, D2664, D2710, D2712, D2720, D2721, D2722, D2740, D2750, D2751, D2752, D2780, D2781, D2782, D2783, D2790, D2791, D2792, D2794, D2931, D2932, D2933), and teeth with extractions (D7140, D7210). Each procedure code can be associated with up to five ICD-9 diagnostic codes. Only the primary diagnostic ICD-9 code was used in these analyses. Outcomes were presented as number of teeth/person receiving cariesrelated treatment and the proportion of patients receiving caries-related treatment. Outcomes were reported for the overall population as well as by tooth location and patient age groups.
Covariates
The sociodemographic covariates of age, gender, race, and ethnicity were included in the analyses. Medical complexity or illness burden was measured using the Selim Comorbidity Index (14, 15) , which was developed and validated in the Veteran ambulatory population. The index comprises a physical component (medical conditions; 30 diagnoses) and a mental component (psychiatric conditions; 6 diagnoses). The physical and mental components were separated because each may make different contributions in health outcomes, and the separation allows for a clearer picture of a patient's overall health status. The diagnostic codes used for each component are available in the Appendix. The comorbidities included all ICD-9 diagnostic codes recorded in the 12 months prior to the caries prevalence period and during the caries prevalence period, for a total of 2 years. The use of prescription medications was determined by counting the number of different VA drug classes prescribed for a period of at least 30 days, extending 12 months prior to the caries prevalence period and during the 12-month caries prevalence period, for a total of 2 years. The VA drug class classification system provides general categories of drugs, and mostly follows the American Hospital Formulary Service Drug Information classes (16) . Finally, to assess the issue of salivary hypo function due to prescription medication use, we utilized the list of drugs with strong anticholinergic properties identified in the 2015 Beers Criteria (17) . This list includes antihistamines, antiparkinsonian agents, skeletal muscle relaxants, antidepressants, antipsychotics, antiarrhythmics, antimuscarinics, antispasmodics, and antiemetics. Of the 52 drugs identified by the Beers Criteria, 45 are available through the VA Pharmacy. Although the Beers Criteria was developed for use in older adults, the VA population is considered "young old" chronologically, presents with greater comorbidity than the general population, and therefore the use of the Beers Criteria is appropriate.
Caries prevalence period determination
The VA's electronic dental record utilizes an odontogram to chart caries, missing teeth, and existing restorations; however, that information is not available on a national level. Only treatment-level data are rolled up to the national level and stored within the central data warehouse. This presented a challenge for the present analyses, because although caries prevalence is measured cross sectionally at one point in time, we had to estimate a suitable time period it would take for a new patient to have their initial burden of caries treated upon becoming eligible to receive dental care in the VA. A caries "prevalence period" was therefore estimated by evaluating the following variables:
• time between a patient's initial and first followup exam; • time between caries-related treatment visits; and • time between a patient's last caries-related treatment visit and first follow-up exam.
The analysis was limited to the first episode of cariesrelated treatment following the initial dental exam and does not include all caries-related treatment during the 5-year study period.
Analyses
Data were merged and descriptive analyses prepared for study outcomes and covariates. Pearson correlation coefficients were calculated for the variables age, prescription VA drug classes, drugs with strong anti-cholinergic properties, physical comorbidity index, and mental comorbidity index. Bivariate analyses examined associations between covariates and outcomes. Logistic and negative binomial regressions modeled teeth with caries-related treatment with all measured covariates. Using both logistic regression and negative binomial regression modeling provided the opportunity to examine which variables were associated with the presence or absence of caries, as well as the magnitude and direction of these associations (18) .
Results
Sample
The inclusion criteria resulted in a study population of 95,850 patients, whose descriptive statistics are presented in Table 1 . A total of 14,527 patients (13.2 percent) were excluded from the analyses because they were edentulous. Within the included study cohort, 92.1 percent were male; the mean age was 58.7 AE 12.6 years; 73.2 percent were White/Caucasian and 21.3 percent were Black/African American. They had a mean of 3.6 AE 2.2 physical comorbidities and 1.4 AE 1.2 mental comorbidities. In addition, they were taking a mean of 10.6 AE 5.9 prescription VA drug classes and a mean of 0.6 AE 0.4 prescription drugs with strong anticholinergic properties.
Caries prevalence period determination
The mean time (days) between the initial and first followup exam was 518 days (~17 months), while the median was 463 days (~15 months) and the mode was 364 days (1 year). Of the 95,850 Veterans, 53,685 (56 percent) received caries-related treatment between their initial and first follow-up exam. For Veterans receiving caries-related treatment, 28,423 of the 53,685 (53 percent) patients had two or more caries-related treatment visits. Veterans with two or more caries-related treatment visits had a mean of three visits (median = 3, mode = 2) and the mean time between caries-related treatments was 123 days (~4 months; median = 80 days, mode = 7 days).
The mean time between the last caries-related visit and first follow-up exam was 258 days [~8.6 months; median = 192 days (~6.4 months)]. As the frequency distributions for the time between the initial exam and first follow-up exam, number of caries-related visits, and days between caries-related visit dates are not normally distributed, the most appropriate measure of central tendency is the median, rather than the mean. Given all this information, for patients requiring caries-related treatment, most would have had all of their treatment completed by 12 months; therefore, a caries prevalence period of 12 months was used for the analyses for all study participants. Although Veterans could enter the dataset throughout the 5-year period, only those with 12 months of follow-up were included in the analyses.
Outcomes
The main outcome of interest was number of teeth/person receiving caries-related treatment, for all new dentate patients, during a 12-month period, beginning with the initial comprehensive exam. This outcome is presented as total teeth/person, anterior versus posterior teeth/person, ICD-9 diagnosis, and age group. The tables also stratify the outcome by type of treatment provided (direct restoration, indirect restoration, and extraction). The secondary outcome was the proportion of patients receiving caries-related treatment.
Of the 95,850 dentate patients, 58 percent (55,583) received caries-related treatment during the 12-month caries prevalence period. As shown in Table 2 , on average, 2.17 teeth/person received caries-related treatment, with direct restorations (1.55 teeth/person; 48 percent of the study population) being the most common, followed by extractions (0.46 teeth/person; 17 percent of the study population), and indirect restorations (0.16 teeth/person; 10 percent of the study population). More posterior teeth (1.36 teeth/person) than anterior teeth (0.81 teeth/person) received caries-related treatment, and this trend was observed across all types of treatments delivered. Not surprisingly, the most common caries-related code for direct and indirect restorations was caries into dentin (ICD-9 521.02), whereas for extractions it was caries into pulp (ICD-9 521.03). The number of teeth/person requiring caries-related treatment increased with age, with the 
Medication use
Ninety-five percent of the study population received at least one prescription VA drug class for 30 days or more during the study period. On average, the study population used a mean of 10.6 AE 5.9 prescription VA drug classes. The top five most commonly prescribed VA drug classes include antilipemic agents, antidepressants, gastric medications, nonopioid analgesics, and nonsalicylate NSAIDS/ antirheumatics. Opioid analgesics were the ninth most commonly prescribed VA drug class. In addition, a mean of 0.6 AE 0.4 drugs with strong anticholinergic properties was prescribed per person.
Pearson correlation coefficient results
A weak correlation was observed between the following pairs of variables: age and physical comorbidities (r = 0.39, P < 0.0001), drugs with strong anticholinergic properties and mental comorbidity index (r = 0.28, P < 0.0001), and drugs with strong anticholinergic properties and prescription VA drug classes (r = 0.39, P < 0.0001). A moderate correlation was observed between prescription VA drug classes and physical comorbidity index (r = 0.57, P < 0.0001).
Logistic and negative binomial regression models
Logistic regression models (used to model caries Yes/No) and negative binomial regression models (used to model number of teeth/person/year with caries) were fit using all 
Discussion
To adequately address disease within a population, it is imperative to understand the burden of the disease and how other factors can modify the disease process. The caries prevalence rate in this study was 58 percent for all new patients, with a mean of 2.17 teeth/dentate person receiving caries-related treatment in the entire study population. Among persons with caries, the mean was 3.75 teeth/ person. In the general US population, the prevalence of untreated dental caries in the 45-64 year age group for 2011-2012 was 26 percent, and when stratified for gender it was 32 percent for males and 20 percent for females (1) . This information points to a notably higher caries risk within the Veteran dental population and indicates that caries risk assessment and prevention strategies are very important for this group. Similar to national statistics (19), we observed increasing caries prevalence with increasing age, except for Veterans over the age of 65 where the caries Shading denotes statistical significance.
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Caries prevalence and associations with medications and medical comorbidities prevalence begins to decrease. We posit this may be due to access to care issues such as lack of transportation to the dental clinic or due to increased medical comorbidities that may limit mobility. Along with this high caries burden, VA dental patients exhibit significant medical comorbidities, with a mean of 3.6 AE 2.2 physical and 1.4 AE 1.2 mental diagnoses per person. The prevalence for some diseases is much higher than that observed in the general US population. Examples include post-traumatic stress disorder (47 percent in VA versus 3.5 percent of US adult population) (20) (20) . It is important to mention that some variability may be due to increased detection related to VA protocols and quality indicators, rather than differences in the prevalence of disease.
Another factor that underscores the medical complexity of the study population is the use of prescription medications and existence of polypharmacy. A mean of 10.6 AE 5.9 different VA drug classes was prescribed per person, along with a mean of 0.6 AE 0.4 drugs with strong anticholinergic properties. Other studies evaluating prescription medication use in the VA have also reported higher rates than the general US population. Rose and colleagues (23) found that in their study cohort of 39,447 Veterans, 61 percent received at least eight nonwarfarin chronic medications, while Watanabe and colleagues (24) found a mean of 7.0 prescription medications in a cohort of 4,886 Veterans. Among US adults, there has been a statistically significant increase in overall use of prescription drugs from 1990 to 2000 (51 percent) and from 2011 to 2012 (59 percent) and polypharmacy, defined as the use of ≥5 prescription drugs, was found in 15 percent of the National Health and Nutrition Examination Survey study population in 2011-2012 (25) . Using this same definition of polypharmacy, 80 percent of the Veterans in our study were prescribed ≥5 VA drug classes. The high use of prescription drugs is likely correlated to the higher prevalence of chronic comorbid illnesses in the VA population. A recent epidemiologic analysis in Sweden (26) found that 33 percent of individuals in the study had at least one decayed surface and that daily medication was statistically associated with manifest caries, after adjusting for age and number of teeth. This information underscores the importance of taking into consideration not just the type of drugs but also the existence of polypharmacy.
It is not discernable from the data as to why a lower rate of caries-related treatment was observed for female (26 percent), Asian and Black/African American (19 percent), and Hispanic (27 percent) Veterans. Given the complexities of the social determinants of health (27, 28) and findings from previous VA studies demonstrating racial and ethnic disparities (29) (30) (31) , future work should examine whether the variation observed represents actual differences in need or differences in treatment provided.
The advantages and disadvantages of utilizing clinical historical dental data have been scrutinized in the literature. Although not a randomized controlled trial, there are definite advantages of using large cohort clinical data to answer research questions. These advantages include large sample size; a valuable source for clinical, comparative and epidemiological data; and, when available, the ability to link large amounts of medical and dental data (8, 32) . In 2015, Jeffcoat (32) provided an editorial response in the Journal of Evidence Based Dentistry, discussing the methods for a large insurance database study. Our current analysis has addressed some of the limitations she described, in that we have refined our data to include information about the subject beyond the dental care provided, including sociodemographic, medical, and pharmacological data. Jeffcoat also discussed the disadvantage of treatment data in many large cohort studies because of the missing element of why treatment was provided. We address this in the current analysis by utilizing provider selected diagnostic codes (ICD-9) for each procedure included in this analysis, thereby focusing only on treatment provided due to caries.
Our study presents with several limitations. We were unable to include the number of existing natural teeth/person, as well as their previous caries experience (DMFT or DMFS) as these data are not rolled up from the individual clinics to the national level and are therefore unavailable in the central data warehouse. Another limitation of our analyses is that the study sample is primarily male, thus limiting generalizability to the general population. However, this study population can be compared to the gender distribution in the general US population, wherein the rate of untreated dental caries in the 45-64 year age group for 2011-2012 was 26 percent, but when stratified for gender it was 32 percent for males and 20 percent for females (1) . The lack of inclusion of a salivary assessment in the analyses presents another study limitation, thereby restricting our ability to determine whether, and to what extent, the use of drugs with strong anticholinergic properties affected salivary flow in our patient population. An additional limitation of this study is the inability to determine caries prevalence cross sectionally, but to estimate a period of time that would be needed to treat caries present at baseline. We deduced a 12-month caries prevalence period, following the evaluation of the time between initial and first follow-up exams, time between caries-related treatments, and time between the last caries-related treatment and first follow-up exam. To examine this further, we completed a sensitivity analysis by extending the caries prevalence period up to 18 months. We found very similar results and therefore are confident that 12 months is a reasonable period of time for a cohort of new patients to have caries present at baseline to be treated. Finally, we used specific treatments for dental caries (restoration or extraction) to assess caries prevalence. It is possible that this was an underestimation as it fails to identify smaller lesions treated with preventive/remineralization services.
By utilizing comprehensive electronic dental, medical, and pharmacy databases, this study of Veteran dental patients enabled us to estimate the prevalence of dental caries in this population and to determine the extent to which prescription medication use and medical comorbidities are associated with caries prevalence. A much higher caries prevalence rate was observed in the study population (58 percent) as compared to the general US adult population (26.6 percent in 2011-2012) (19) . While published literature has mostly focused on the association of xerostomic medications and caries (33, 34) , we found a stronger relationship between caries prevalence and polypharmacy than with the use of drugs with strong anticholinergic properties. Furthermore, we found a weak correlation between the number of prescription medications and drugs with strong anticholinergic properties. Caries risk assessment tools, including the American Dental Association's caries risk assessment form for age > 6 (35) and caries management by risk assessment (CAMBRA) (36) include medications that reduce salivary flow in their assessments, but do not address polypharmacy. The information gained from this study will be incorporated into the VA's subjective caries risk assessment tool contained within the electronic dental record, with the goal of improving the quality of care for our nation's Veterans.
